11.66
price down icon10.79%   -1.41
pre-market  시장 영업 전:  11.72   0.06   +0.51%
loading
전일 마감가:
$13.07
열려 있는:
$12.86
하루 거래량:
971.76K
Relative Volume:
0.33
시가총액:
$18.47M
수익:
$74,000
순이익/손실:
$-13.43M
주가수익비율:
-1.2404
EPS:
-9.4
순현금흐름:
$-10.54M
1주 성능:
+252.27%
1개월 성능:
+3,320%
6개월 성능:
+102.43%
1년 성능:
-56.36%
1일 변동 폭
Value
$11.32
$14.37
1주일 범위
Value
$4.55
$19.25
52주 변동 폭
Value
$0.215
$39.84

Cyclacel Pharmaceuticals Inc Stock (CYCC) Company Profile

Name
명칭
Cyclacel Pharmaceuticals Inc
Name
전화
908-517-7330
Name
주소
200 CONNELL DRIVE, BERKELEY HEIGHTS, NJ
Name
직원
12
Name
트위터
Name
다음 수익 날짜
2024-11-11
Name
최신 SEC 제출 서류
Name
CYCC's Discussions on Twitter

CYCC을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
CYCC
Cyclacel Pharmaceuticals Inc
11.66 5.24M 74,000 -13.43M -10.54M -9.40
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
458.49 121.30B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.53 61.60B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.52 41.17B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
566.14 34.35B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
291.93 27.29B 3.81B -644.79M -669.77M -6.24

Cyclacel Pharmaceuticals Inc Stock (CYCC) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2022-07-18 재개 Oppenheimer Outperform
2020-04-27 재개 ROTH Capital Buy
2018-09-07 개시 Ladenburg Thalmann Buy
2015-10-16 개시 H.C. Wainwright Buy
2010-02-04 개시 Roth Capital Buy
2009-10-28 개시 Merriman Buy
2008-08-12 개시 Piper Jaffray Buy
2008-03-12 재확인 Cantor Fitzgerald Buy
2008-03-12 재확인 Collins Stewart Buy
2008-03-12 재확인 Needham & Co Buy
2007-11-27 재확인 Cantor Fitzgerald Buy
2007-08-10 재확인 Cantor Fitzgerald Buy
2007-06-04 재확인 Needham & Co Buy
2007-04-23 개시 Lazard Capital Buy
2007-04-10 개시 Cantor Fitzgerald Buy
모두보기

Cyclacel Pharmaceuticals Inc 주식(CYCC)의 최신 뉴스

pulisher
Jul 21, 2025

Is Cyclacel Pharmaceuticals Inc. a good long term investmentDynamic profit opportunities - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

What analysts say about Cyclacel Pharmaceuticals Inc. stockExceptional market positioning - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

CYCC’s Financial Health: Exploring Cyclacel Pharmaceuticals Inc’s Debt-to-Equity Ratio of 1.79 - investchronicle.com

Jul 21, 2025
pulisher
Jul 21, 2025

Cyclacel Plunges 11.09% on Revenue Guidance Cut - AInvest

Jul 21, 2025
pulisher
Jul 20, 2025

Wall Street Zen Downgrades Cyclacel Pharmaceuticals (NASDAQ:CYCC) to Sell - Defense World

Jul 20, 2025
pulisher
Jul 19, 2025

Cyclacel Pharmaceuticals Inc. Stock Analysis and ForecastHigh-octane financial growth - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

What drives Cyclacel Pharmaceuticals Inc. stock priceExceptional trading performance - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 17, 2025

CYCLACEL PHARMACEUTICALS INC 6% CNV PFD USD To Go Ex-Dividend On July 21st, 2025 With 0.15 USD Dividend Per Share - 富途牛牛

Jul 17, 2025
pulisher
Jul 16, 2025

Big Moves And Bigger Questions For Biotech And Tech Stocks - Finimize

Jul 16, 2025
pulisher
Jul 16, 2025

Cyclacel stock falls after paring 270% gain amid volatility concerns By Investing.com - Investing.com Canada

Jul 16, 2025
pulisher
Jul 16, 2025

Cyclacel stock dips after trimming 270% surge amid volatility concerns - MSN

Jul 16, 2025
pulisher
Jul 16, 2025

Cyclacel Shares Plunge 36% Amid Volatility, What's Driving the Sell-Off? - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Cyclacel stock falls after paring 270% gain amid volatility concerns - Investing.com Australia

Jul 16, 2025
pulisher
Jul 16, 2025

Cyclacel Pharmaceuticals Addresses Recent Stock Price Volatility Amid Ongoing Business Developments - Quiver Quantitative

Jul 16, 2025
pulisher
Jul 16, 2025

CYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY - Yahoo Finance

Jul 16, 2025
pulisher
Jul 16, 2025

Cyclacel Pharmaceuticals Stock Plunges 37.23% - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Cyclacel Pharmaceuticals Stock Surges Amid Positive Research Findings - AInvest

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Cyclacel Pharmaceuticals Inc. stock price move sharplyHigh Potential Stock Ideas - beatles.ru

Jul 15, 2025
pulisher
Jul 15, 2025

Why Cyclacel Pharmaceuticals Inc. stock attracts strong analyst attentionExpert Backed Predictions - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Is Cyclacel Pharmaceuticals Stock Soaring On Tuesday? - Benzinga

Jul 15, 2025
pulisher
Jul 15, 2025

Cyclacel's Volatile Surge: Can This Biotech Stock Defy Gravity? - AInvest

Jul 15, 2025
pulisher
Jul 15, 2025

Cyclacel Pharmaceuticals Stock Soars: Investing or Waiting? - timothysykes.com

Jul 15, 2025
pulisher
Jul 12, 2025

Cyclacel Pharmaceuticals (NASDAQ:CYCC) Upgraded by Wall Street Zen to “Hold” Rating - Defense World

Jul 12, 2025
pulisher
Jul 08, 2025

Fitters: US$1m cash added to Cyclacel deal to address stock volatility since signing - The Malaysian Reserve

Jul 08, 2025
pulisher
Jul 07, 2025

Cyclacel Stock Surges 50% After Amending Exchange Agreement with FITTERS - MSN

Jul 07, 2025
pulisher
Jul 07, 2025

Cyclacel stock soars after amendment to exchange agreement with FITTERS By Investing.com - Investing.com Nigeria

Jul 07, 2025
pulisher
Jul 07, 2025

Cyclacel stock soars after amendment to exchange agreement with FITTERS - Investing.com Australia

Jul 07, 2025
pulisher
Jul 07, 2025

Cyclacel sweetens Fitters acquisition deal with US$1m cash addition - The Malaysian Reserve

Jul 07, 2025
pulisher
Jul 07, 2025

Cyclacel Pharmaceuticals Amends Exchange Agreement with FITTERS - TipRanks

Jul 07, 2025
pulisher
Jul 07, 2025

CYCLACEL PHARMACEUTICALS HIGHLIGHTS PUBLICATION OF PRECLINICAL DATA SHOWING THAT PLOGOSERTIB IS ACTIVE IN A HARD-TO-TREAT SUBTYPE OF LIVER CANCER - The Manila Times

Jul 07, 2025
pulisher
Jul 07, 2025

Breakthrough: New Drug Shows Effectiveness Against Untreatable Youth Liver Cancer, Research Reveals - Stock Titan

Jul 07, 2025
pulisher
Jul 04, 2025

Cyclacel Pharmaceuticals adjusts shareholder rights, amends stock - MSN

Jul 04, 2025
pulisher
Jul 03, 2025

Cyclacel Pharmaceuticals to Acquire Fitters Sdn. Bhd. Through Share Exchange Agreement - Global Legal Chronicle

Jul 03, 2025
pulisher
Jul 02, 2025

Cyclacel Pharmaceuticals Announces 1-for-15 Reverse Stock Split Effective July 7, 2025 - Nasdaq

Jul 02, 2025
pulisher
Jul 02, 2025

Cyclacel Pharmaceuticals Announces Stock Split - Morningstar

Jul 02, 2025
pulisher
Jul 02, 2025

Cyclacel Announces Major Share Restructuring: 23.7M Shares Consolidating to 1.58M - Stock Titan

Jul 02, 2025
pulisher
Jul 01, 2025

Cyclacel Pharmaceuticals shareholders re-elect directors and approve equity plan changes - Investing.com India

Jul 01, 2025
pulisher
Jun 30, 2025

Cyclacel Pharmaceuticals Approves Equity Plan Amendment - TipRanks

Jun 30, 2025
pulisher
Jun 20, 2025

Cyclacel Stock Tumbles Over 76% Since Regaining Nasdaq Compliance: What’s Ailing the Nanocap Biopharma Firm? - Investing.com India

Jun 20, 2025
pulisher
Jun 20, 2025

Cyclacel Raises $3M Through Preferred Stock Deal: New Warrants Unveiled at $0.51-$0.68 Exercise Price - Stock Titan

Jun 20, 2025
pulisher
Jun 12, 2025

Why Did Cyclacel Pharmaceuticals Inc. (CYCC) Soar 13.92%? - AInvest

Jun 12, 2025

Cyclacel Pharmaceuticals Inc (CYCC) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$21.69
price down icon 0.87%
$35.65
price up icon 0.17%
$102.78
price up icon 0.22%
$26.34
price up icon 0.53%
$108.91
price down icon 1.01%
biotechnology ONC
$291.93
price down icon 0.89%
자본화:     |  볼륨(24시간):